Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease

Journal of Thoracic and Cardiovascular Surgery

Volumn 115, Issue 4, 1998, Pages 875-882

  Ivy, D D ^a   Kinsella, J P ^a   Ziegler, J W ^a   Abman, S H ^a  

^a CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR;

ADULT; AORTA PRESSURE; ARTERIAL PRESSURE; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; HUMAN; HYDROLYSIS; INFANT; LUNG ARTERY PRESSURE; NEWBORN; OXYGEN SATURATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SMOOTH MUSCLE; VENOUS OXYGEN TENSION;

EID: 0031965802     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(98)70369-1     Document Type: Article

References (30)

1. DL Wessel I Adatia TM Giglia JE Thompson TJ. Kulik Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass Circulation 88 1993 2128 2138
2. D Journois P Pouard P Mauriat T Malhere P Vouhe D Safran Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects J Thorac Cardiovasc Surg 107 1994 1129 1135
3. DD Ivy JP Kinsella RR Wolfe SH Abman Atrial natriuretic peptide and nitric oxide in children with pulmonary hypertension after surgical repair of congenital heart disease Am J Cardiol 77 1996 102 105
4. A Lavoie JB Hall DM Olson ME Wylam Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure Am J Respir Crit Care Med 153 1996 1985 1987
5. JP Kinsella SR Neish DD Ivy E Shaffer SH Abman Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide J Pediatr 123 1993 103 108
6. OI Miller SF Tang A Keech DS. Celermajer Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide Lancet 346 1995 51 52
7. R Rossaint KJ Falke F Lopez K Slama U Pison WM Zapol Inhaled nitric oxide for the adult respiratory distress syndrome N Engl J Med 328 1993 399 405
8. AM Atz I Adatia DL. Wessel Rebound pulmonary hypertension after inhalation of nitric oxide Ann Thorac Surg 62 1996 1759 1764
9. A Giaid D Saleh Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension N Engl J Med 333 1995 214 221
10. A Giaid M Yanagisawa D Langleben Expression of endothelin-1 in the lungs of patients with pulmonary hypertension N Engl J Med 328 1993 1732 1739
11. GM Buga JM Griscavage NE Rogers LJ. Ignarro Negative feedback regulation of endothelial cell function by nitric oxide Circ Res 73 1993 808 812
12. A Rengasamy RA. Johns Regulation of nitric oxide synthase by nitric oxide Mol Pharmacol 44 1993 124 128
13. M Oka M Ohnishi H Takahashi Altered vasoreactivity in lungs isolated from rats exposed to nitric oxide gas Am J Physiol 271 1996 L419 L424
14. AH Cohen K Hanson K Morris Inhibition of cyclic 3`-5`-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats J Clin Invest 97 1996 172 179
15. KA Hanson SH Abman WR. Clarke Elevation of pulmonary PDE5-specific activity in an experimental fetal pulmonary hypertension model [abstract] Pediatr Res 39 1996 334A
16. F Ichinose C Adrie WE Hurford WM Zapol Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs J Appl Physiol 78 1995 1288 1295
17. KG Thusu FCr Morin JA Russell RH Steinhorn The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide Am J Respir Crit Care Med 152 1995 1605 1610
18. JW Ziegler DD Ivy JJ Fox JP Kinsella WR Clarke SH Abman Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus Am J Physiol 269 1995 H473 H479
19. DA Braner JR Fineman R Chang SJ Soifer M&B 22948, a cGMP phosphodiesterase inhibitor, is a pulmonary vasodilator in lambs Am J Physiol 264 1993 H252 H258
20. JP Kinsella F Torielli JW Ziegler DD Ivy SH. Abman Dipyridamole augmentation of response to nitric oxide Lancet 346 1995 647 648
21. DA Fullerton J Jaggers F Piedalue FL Grover RC McIntyre Effective control of refractory pulmonary hypertension after cardiac operations J Thorac Cardiovasc Surg 113 1997 363 370
22. S al-Alaiyan A al-Omran D. Dyer The use of phosphodiesterase inhibitor (dipyridamole) to wean from inhaled nitric oxide Intensive Care Med 22 1996 1093 1095
23. SH Abman JL Griebel DK Parker JM Schmidt D Swanton JP Kinsella Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure J Pediatr 124 1994 881 888
24. JP Kinsella SR Neish E Shaffer SH. Abman Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn Lancet 340 1992 819 820
25. J Roberts Jr P Lang LM Bigatello GJ Vlahakes WM. Zapol Inhaled nitric oxide in congenital heart disease Circulation 87 1993 447 453
26. N Fukushima SR Gundry AJ Razzouk LL Bailey Risk factors for graft failure associated with pulmonary hypertension after pediatric heart transplantation J Thorac Cardiovasc Surg 107 1994 985 989
27. J Mlczoch EK Weir RF Grover Inhibition of hypoxic pulmonary vasoconstriction by dipyridamole is not platelet mediated Can J Physiol Pharmacol 55 1977 448 451
28. Ziegler JW, Ivy DD, Fox JJ, Kinsella JP, Clarke WR, Abman SH. Dipyridamole, a cGMP phosphodiesterase inhibitor, augments endothelium-independent vasodilation in the ovine fetal lung. Am J Respir Crit Care Med. In press.
29. T Munzel H Sayegh BA Freeman MM Tarpey DG Harrison Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance J Clin Invest 95 1995 187 194
30. LJ Rubin BM Groves JT Reeves M Frosolono F Handel AE. Cato Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension Circulation 66 1982 334 338